The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
Palmer Candy President and CEO Marty Palmer declined to identify which of his company's products contain FD&C Red No. 3, but it is listed on the Twin Bing packaging. He says the company shouldn't have ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
That’s because there is an inverse relationship between presidential approval ratings and the stock market, according to an analysis conducted by Ned Davis Research. Donald Trump’s approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback